EZH2 and breast cancer: Another inhibitor of EZH2 is 3-Deazaneplanocin A (DZNep), which alters methionine metabolism; it degrades EZH2 and inhibits H3K27 methylation, thereby inducing apoptosis in MCF7 breast cancer cells and HCT116 colorectal cancer cells [143].